These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 16901772)

  • 1. Bone tissue compositional differences in women with and without osteoporotic fracture.
    McCreadie BR; Morris MD; Chen TC; Sudhaker Rao D; Finney WF; Widjaja E; Goldstein SA
    Bone; 2006 Dec; 39(6):1190-5. PubMed ID: 16901772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low bone mineral density and fracture burden in postmenopausal women.
    Cranney A; Jamal SA; Tsang JF; Josse RG; Leslie WD
    CMAJ; 2007 Sep; 177(6):575-80. PubMed ID: 17846439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancellous and cortical bone architecture and turnover at the iliac crest of postmenopausal osteoporotic women treated with parathyroid hormone 1-84.
    Recker RR; Bare SP; Smith SY; Varela A; Miller MA; Morris SA; Fox J
    Bone; 2009 Jan; 44(1):113-9. PubMed ID: 18983947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tamoxifen use and osteoporotic fracture risk: a population-based analysis.
    Cooke AL; Metge C; Lix L; Prior HJ; Leslie WD
    J Clin Oncol; 2008 Nov; 26(32):5227-32. PubMed ID: 18838712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cortical and trabecular bone distribution in the femoral neck in osteoporosis and osteoarthritis.
    Blain H; Chavassieux P; Portero-Muzy N; Bonnel F; Canovas F; Chammas M; Maury P; Delmas PD
    Bone; 2008 Nov; 43(5):862-8. PubMed ID: 18708176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Population-based study of the effectiveness of bone-specific drugs in reducing the risk of osteoporotic fracture.
    Perreault S; Dragomir A; Blais L; Moride Y; Rossignol M; Ste-Marie LG; Fernandès JC
    Pharmacoepidemiol Drug Saf; 2008 Mar; 17(3):248-59. PubMed ID: 18213734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in osteocyte density and bone histomorphometry between men and women and between healthy and osteoporotic subjects.
    Mullender MG; Tan SD; Vico L; Alexandre C; Klein-Nulend J
    Calcif Tissue Int; 2005 Nov; 77(5):291-6. PubMed ID: 16307389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hot flushes, bone mineral density, and fractures in older postmenopausal women.
    Huang A; Grady D; Blackwell T; Bauer D
    Obstet Gynecol; 2007 Apr; 109(4):841-7. PubMed ID: 17400844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteodensitometry in healthy postmenopausal women.
    Prescrire Int; 2008 Apr; 17(94):68-72. PubMed ID: 18536138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low calcaneal bone mineral density and the risk of distal forearm fracture in women and men: a population-based case-control study.
    Atroshi I; Ahlander F; Billsten M; Ahlborg HG; Mellström D; Ohlsson C; Ljunggren O; Karlsson MK
    Bone; 2009 Oct; 45(4):789-93. PubMed ID: 19539795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infrared spectroscopy and magnesium content of bone mineral in osteoporotic women.
    Cohen L; Kitzes R
    Isr J Med Sci; 1981 Dec; 17(12):1123-5. PubMed ID: 7327911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment strategies for patients with low bone mass: the younger postmenopausal female.
    Honig S
    Bull NYU Hosp Jt Dis; 2008; 66(3):240-3. PubMed ID: 18937639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vertebral fractures are associated with increased cortical porosity in iliac crest bone biopsy of men with idiopathic osteoporosis.
    Ostertag A; Cohen-Solal M; Audran M; Legrand E; Marty C; Chappard D; de Vernejoul MC
    Bone; 2009 Mar; 44(3):413-7. PubMed ID: 19071239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of depressive symptoms in postmenopausal women with low bone mineral density and/or prevalent vertebral fracture: results from the Multiple Outcomes of Raloxifene Evaluation (MORE) study.
    Silverman SL; Shen W; Minshall ME; Xie S; Moses KH
    J Rheumatol; 2007 Jan; 34(1):140-4. PubMed ID: 17216681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective effect of beta blockers in postmenopausal women: influence on fractures, bone density, micro and macroarchitecture.
    Bonnet N; Gadois C; McCloskey E; Lemineur G; Lespessailles E; Courteix D; Benhamou CL
    Bone; 2007 May; 40(5):1209-16. PubMed ID: 17324648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone mass measurement and factors associated with risk of fracture in a group of peri- and postmenoupausal women.
    Rasheed A; Khurshid R; Aftab L
    J Ayub Med Coll Abbottabad; 2008; 20(1):48-51. PubMed ID: 19024185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Skeletal actions of intermittent parathyroid hormone: effects on bone remodelling and structure.
    Compston JE
    Bone; 2007 Jun; 40(6):1447-52. PubMed ID: 17045858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical risk factors for fracture in postmenopausal osteoporotic women: a review of the recent literature.
    LaFleur J; McAdam-Marx C; Kirkness C; Brixner DI
    Ann Pharmacother; 2008 Mar; 42(3):375-86. PubMed ID: 18230704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The microanatomy of trabecular bone in young normal and osteoporotic elderly males.
    Shahtaheri SM
    Aging Male; 2007 Jun; 10(2):71-5. PubMed ID: 17558971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing compliance, acceptance, and tolerability of teriparatide in patients with osteoporosis who fractured while on antiresorptive treatment or were intolerant to previous antiresorptive treatment: an 18-month, multicenter, open-label, prospective study.
    Adachi JD; Hanley DA; Lorraine JK; Yu M
    Clin Ther; 2007 Sep; 29(9):2055-67. PubMed ID: 18035204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.